A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Lamivudine and Tenofovir Disoproxil (CIMDUO)

Lamivudine and Tenofovir Disoproxil suppresses hepatitis B virus replication.

First FDA approval2018-06-25
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
/unit
0 NDCs benchmarked, lowest of all strengths.
Average NADAC
Across all dosage forms in distribution.
Highest NADAC
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema10 entries indexed · 4 visible
What is Lamivudine and Tenofovir Disoproxil used for?

Lamivudine and Tenofovir Disoproxil suppresses hepatitis B virus replication.

Is there a generic for Lamivudine and Tenofovir Disoproxil?

No. Lamivudine and Tenofovir Disoproxil is brand-only with no generic equivalents currently in market.

How much does my plan pay for Lamivudine and Tenofovir Disoproxil?

NADAC pricing data not currently available for this drug.

Is Lamivudine and Tenofovir Disoproxil on the FDA shortage list?

No. Lamivudine and Tenofovir Disoproxil is not currently on the FDA Drug Shortage Database.

6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor6 alternatives in D1
01
Abacavir , Lamivudine and Zidovudine
Brand: ABACAVIR, LAMIVUDINE AND ZIDOVUDINE
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
02
Abacavir Sulfate, Dolutegravir Sodium, Lamivudine
Brand: Triumeq
$130.00Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
03
Abacavir and Lamivudine
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
$1.26Lowest NADAC
5Generic mfrs
CY24 Part D spend
Compare →
04
Dolutegravir and Lamivudine
Brand: Dovato
$105.29Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
05
Entecavir
Brand: BARACLUDE
$0.222Lowest NADAC
8Generic mfrs
$44.1MCY24 Part D spend
Compare →
06
Lamivudine
Brand: EPIVIR
$0.249Lowest NADAC
10Generic mfrs
$8.4MCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (1 approvals on file) · NADAC unit costs: CMS NADAC weekly file · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.